Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Phase I Study to Assess PSMA+ and PSMA- Tumour Lesions

Crescendo Biologics Ltd. · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
advanced and/or metastatic solid tumours, phase 1 study, solid tumours, castration-resistant prostate cancer (crpc), prostate specific membrane antigen (psma), crescendo biologics, cd137, cb307, humabody®, radiolabelled cb307, 89-zirconium, biodistribution
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 831928
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.